This book describes factors leading to the state of degeneration including depletion of minerals, poor nutrition, depleted level of oxygen, stress, environmental and chemical pollution. The book emphasizes that correcting these factors will remove risk of recurrence, hasten recovery and the body will return to good health and enjoy longevity. An important message is that chelation is a more natural first option. However, unless the origin is corrected, the disease process continues causing the condition to recur and present more serious health problems. This message leads to the importance of a lifestyle change, a new consciousness of a self help take charge implementing a support program to maximize the outcome of chelation and return to good health.

This work goes beyond the description of the nutritional chemistry of minerals as electrolytes. This book presents evidence of how factors in our lifestyle and polluted environment are insidiously contributing to a cumulative depletion of minerals that is the cause of our escalating level of morbidity statistics - most illness, degenerative disease, premature deaths and aging. The author claims breakthrough research experience with over a thousand patients explaining how depleting levels of electrolytes alter alkaline pH causing acid damage to cells and toxic overload responsible for illness and disease.

More than one million Americans undergo heart bypass surgery and balloon angioplasty every year at a cost of fifty billion dollars. But there is a simple, nonsurgical method to open clogged arteries that is administered in the doctor's office. Chelation therapy works in all the arteries at once, it's much safer, and is much less expensive.

This Volume of the series Cardiac and Vascular Biology offers a comprehensive and exciting, state-of-the-art work on the current options and potentials of cardiac regeneration and repair. Several techniques and approaches have been developed for heart failure repair: direct injection of cells, programming of scar tissue into functional myocardium, and tissue-engineered heart muscle support. The book introduces the rationale for these different approaches in cell-based heart regeneration and discusses the most important considerations for clinical translation. Expert authors discuss when, why, and how heart muscle can be salvaged. The book represents a valuable resource for stem cell researchers, cardiologists, bioengineers, and biomedical scientists studying cardiac function and regeneration.

Small, mighty, and packed with information, The Washington Manual: Cardiology Subspecialty Consult, 3e places the field of cardiovascular disease at your fingertips. Designed for the busy practitioner, student, or resident, this pocket-sized edition captures cardiology’s latest findings and treatments in an easy-to-read format. In a fast-advancing field that welcomes new biomedical discoveries and novel therapeutics, this resource delivers top treatment recommendations for your patients. If you’re a busy clinician committed to exceptional, cost-effective patient care, The Washington Manual: Cardiology Subspecialty Consult is the guide for you. FEATURES --NEW chapters on the physical exam, heart failure, preserved ejection fraction, and cardiovascular diseases in special populations --Guidelines from the American Heart Association and American College of Cardiology --End-of-chapter journal and online references --Maximum readability with diagrams, flow charts, bullet-point lists, bold faced call-outs, and mnemonics Now with the print edition, enjoy the bundled interactive eBook edition, offering tablet, smartphone, or online access to: Complete content with enhanced navigation A powerful search that pulls results from content in the book, your notes, and even the web Cross-linked pages, references, and more for easy navigation Highlighting tool for easier reference of key content throughout the text Ability to take and share notes with friends and colleagues Quick reference tabbing to save your favorite content for future use

Chelation therapy, based on the intravenous infusion of EDTA, is a highly effective treatment for atherosclerotic cardiovasular disease. Saftey and effectivenss are well documented in clinical studies, all of which to date are supportive of this therapy, and there are no studies showing lack of effectiveness. A strong case is made for the use of this safe, efficacious, and inexpensive therapy before resorting to surgery and other risky and invasive treatments. In this newly revised and extensively updated edition of what has come to be regarded as the definitive textbook on the subject, renowned chelation expert Elmer M. Cranton, M.D., presents the work of the world's leading experts in chelation therapy. "This therapy has been proven effective over and over again in clinical practice," says Dr. Cranton. "More than one million patients have recieved more than twenty million infusions with no serious or lasting adverse effects." In his foreword, Nobel Prize winner Dr. Linus Pauling states, "EDTA chelation therapy makes good sense to me as a chemist and medical researcher. It has a rational scientific basis, and the evidence for clinical benefit seems to be quite strong." Here in a single volume you will learn everything you need to know to responsibly administer and advocate chelation therapy. You will find a coherent scientific rationale, clinical trials demonstating effectiveness, guidelines for saftey, detailed protocols for administration, and techniques for pre- and post-treatment laboratory evalutaion.

This is the first textbook to focus on Aortopathy, a new clinical concept for a form of vasculopathy. The first section of the book starts from discussing general concept and history of Aortopathy, and then deals with its pathophysiology, manifestation, intrinsic factor, clinical implication, management and prevention. The second part closely looks at various disorders of the Aortopathy such as bicuspid aortic valve and coarctation of aorta. The book editors have published a lot of works on the topic and have been collecting relating data in the field of congenital heart disease for the past 20 years, thus present the book with confidence. The topic - an association of aortic pathophysiological abnormality, aortic dilation and aorto-left ventricular interaction - is getting more and more attention among cardiovascular physicians. This is the first book to refer for cardiologists, pediatric cardiologists, surgeons, ACHD specialists, etc. to acquire thorough knowledge on Aortopathy.

Drawing on solid scientific evidence as well as extensive first-hand experience, this manual provides the practical information you need to safely and effectively integrate complementary and alternative treatment modalities into your practice. It explains how alternative therapies can help you fight diseases that do not respond readily to traditional treatments... presents integrative treatments for a full range of diseases and conditions, including autism, stroke, chronic fatigue syndrome, and various forms of cancer...explores how to advise patients on health maintenance and wellness...and offers advice on topics such as meditation, diet, and exercises for back pain. 24 new chapters, a new organization, make this landmark reference more useful than ever. Provides dosages and precautions to help you avoid potential complications.Delivers therapy-based pearls to enhance your patient care.Facilitates patient education with helpful handouts. Offers helpful icons that highlight the level and quality of evidence for each specific modality.Includes bonus PDA software that lets you load all of the therapeutic review sections onto your handheld device.Presents a new organization, with numerous section headings and subheadings, for greater ease of reference.Provides additional clinical practice and business considerations for incorporating integrative medicine into clinical practice.

Among the many who serve in the United States Armed Forces and who are deployed to distant locations around the world, myriad health threats are encountered. In addition to those associated with the disruption of their home life and potential for combat, they may face distinctive disease threats that are specific to the locations to which they are deployed. U.S. forces have been deployed many times over the years to areas in which malaria is endemic, including in parts of Afghanistan and Iraq. Department of Defense (DoD) policy requires that antimalarial drugs be issued and regimens adhered to for deployments to malaria-endemic areas. Policies directing which should be used as first and as second-line agents have evolved over time based on new data regarding adverse events or precautions for specific underlying health conditions, areas of deployment, and other operational factors At the request of the Veterans Administration, Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis assesses the scientific evidence regarding the potential for long-term health effects resulting from the use of antimalarial drugs that were approved by FDA or used by U.S. service members for malaria prophylaxis, with a focus on mefloquine, tafenoquine, and other antimalarial drugs that have been used by DoD in the past 25 years. This report offers conclusions based on available evidence regarding associations of persistent or latent adverse events.

Chelation Therapy in the Treatment of Metal Intoxication presents a practical guide to the use of chelation therapy, from its basic chemistry, to available chelating antidotes, and the application of chelating agents. Several metals have long been known to be toxic to humans, and continue to pose great difficulty to treat. These challenges pose particular problems in industrial settings, with lead smelting known to be associated with hemopoietic alterations and paralyses, and the inhalation of mercury vapor in mercury mining being extremely detrimental to the central nervous system. Clinical experience has demonstrated that acute and chronic human intoxications with a range of metals can be treated efficiently by administration of chelating agents. Chelation Therapy in the Treatment of Metal Intoxication describes the chemical and biological principles of chelation in the treatment of these toxic metal compounds, including new chelators such as meso-2,3-dimercaptosuccinic acid (DMSA) and D,L-2,3-dimercapto-1-propanesulfonic acid (DMPS). Presents all the current findings on the potential for chelation as a therapy for metal intoxication Presents practical guidelines for selecting the most appropriate chelating agent Includes coverage on radionuclide exposure and metal storage diseases Describes the chemical and biological principles of chelation in the treatment of toxic metal compounds